The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial (Q31132696)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial
scientific article

    Statements

    The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial (English)
    A Enrique Caballero
    Karim Abou-Elenin
    Colleen O'Connor
    Frank W Logerfo
    Aristidis Veves
    1 February 2003

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit